[go: up one dir, main page]

ITFI920052A1 - Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. - Google Patents

Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.

Info

Publication number
ITFI920052A1
ITFI920052A1 IT000052A ITFI920052A ITFI920052A1 IT FI920052 A1 ITFI920052 A1 IT FI920052A1 IT 000052 A IT000052 A IT 000052A IT FI920052 A ITFI920052 A IT FI920052A IT FI920052 A1 ITFI920052 A1 IT FI920052A1
Authority
IT
Italy
Prior art keywords
antigen
helicobacter pylori
protein
vaccine
expresses
Prior art date
Application number
IT000052A
Other languages
English (en)
Inventor
Doretta Armellini
Massimo Bugnoli
Stefano Censini
Antonio Covacci
Natale Figura
Roberto Petracca
Rino Rappuoli
Original Assignee
Istituto Ricerche Immunobiologiche Siena S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Ricerche Immunobiologiche Siena S R L filed Critical Istituto Ricerche Immunobiologiche Siena S R L
Publication of ITFI920052A0 publication Critical patent/ITFI920052A0/it
Priority to ITFI920052A priority Critical patent/IT1262895B/it
Priority to AT99202698T priority patent/ATE382692T1/de
Priority to CA002383007A priority patent/CA2383007A1/en
Priority to AT93905285T priority patent/ATE245698T1/de
Priority to DE69333110T priority patent/DE69333110T2/de
Priority to PCT/EP1993/000472 priority patent/WO1993018150A1/en
Priority to SG1996009100A priority patent/SG48353A1/en
Priority to DE69334197T priority patent/DE69334197T2/de
Priority to AU36300/93A priority patent/AU3630093A/en
Priority to EP93905285A priority patent/EP0643770B1/en
Priority to EP99202698A priority patent/EP0967279B1/en
Priority to CA002131729A priority patent/CA2131729C/en
Priority to JP51530993A priority patent/JP3368902B2/ja
Publication of ITFI920052A1 publication Critical patent/ITFI920052A1/it
Priority to US08/470,260 priority patent/US6077706A/en
Priority to US08/466,662 priority patent/US6130059A/en
Priority to US08/471,491 priority patent/US6090611A/en
Priority to US08/477,451 priority patent/US5928865A/en
Application granted granted Critical
Publication of IT1262895B publication Critical patent/IT1262895B/it
Priority to US09/360,685 priority patent/US7141244B1/en
Priority to JP2000126696A priority patent/JP2000333686A/ja
Priority to JP2000126695A priority patent/JP3408494B2/ja
Priority to US09/921,157 priority patent/US20040048353A1/en
Priority to JP2003008806A priority patent/JP4271952B2/ja
Priority to US10/615,668 priority patent/US7700755B2/en
Priority to JP2005263068A priority patent/JP2006055168A/ja
Priority to US11/580,632 priority patent/US20070243204A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ITFI920052A 1992-03-02 1992-03-02 Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. IT1262895B (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
ITFI920052A IT1262895B (it) 1992-03-02 1992-03-02 Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
JP51530993A JP3368902B2 (ja) 1992-03-02 1993-03-02 ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質
CA002383007A CA2383007A1 (en) 1992-03-02 1993-03-02 Helicobacter pylori proteins useful for vaccines and diagnostics
AT93905285T ATE245698T1 (de) 1992-03-02 1993-03-02 Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose
DE69333110T DE69333110T2 (de) 1992-03-02 1993-03-02 Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose
PCT/EP1993/000472 WO1993018150A1 (en) 1992-03-02 1993-03-02 Helicobacter pylori proteins useful for vaccines and diagnostics
SG1996009100A SG48353A1 (en) 1992-03-02 1993-03-02 Helicobacter pylori proteins useful for vaccines and diagnostics
DE69334197T DE69334197T2 (de) 1992-03-02 1993-03-02 Helicobacter pylori Cytotoxin verwendbar in Impfstoffe und Diagnostik
AU36300/93A AU3630093A (en) 1992-03-02 1993-03-02 Helicobacter pylori proteins useful for vaccines and diagnostics
EP93905285A EP0643770B1 (en) 1992-03-02 1993-03-02 Helicobacter pylori cytotoxin associated immunodominant antigen useful for vaccines and diagnostics
EP99202698A EP0967279B1 (en) 1992-03-02 1993-03-02 Helicobacter pylori cytotoxin useful for vaccines and diagnostics
CA002131729A CA2131729C (en) 1992-03-02 1993-03-02 Helicobacter pylori proteins useful for vaccines and diagnostics
AT99202698T ATE382692T1 (de) 1992-03-02 1993-03-02 Helicobacter pylori cytotoxin verwendbar in impfstoffe und diagnostik
US08/471,491 US6090611A (en) 1992-03-02 1995-06-06 Helicobacter pylori proteins useful for vaccines and diagnostics
US08/470,260 US6077706A (en) 1992-03-02 1995-06-06 Helicobacter pylori proteins useful for vaccines and diagnostics
US08/466,662 US6130059A (en) 1992-03-02 1995-06-06 Helicobacter pylori proteins useful for vaccines and diagnostics
US08/477,451 US5928865A (en) 1992-03-02 1995-06-07 Compositions comprising isolated Helicobacter pylori CagI polynucleotides and method of preparation thereof
US09/360,685 US7141244B1 (en) 1992-03-02 1999-07-26 Helicobacter pylori proteins useful for vaccines and diagnostics
JP2000126696A JP2000333686A (ja) 1992-03-02 2000-04-26 ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質
JP2000126695A JP3408494B2 (ja) 1992-03-02 2000-04-26 ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質
US09/921,157 US20040048353A1 (en) 1992-03-02 2001-08-02 Helicobacter pylori proteins useful for vaccines and diagnostics
JP2003008806A JP4271952B2 (ja) 1992-03-02 2003-01-16 ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質
US10/615,668 US7700755B2 (en) 1992-03-02 2003-07-08 Helicobacter pylori CAI antigen
JP2005263068A JP2006055168A (ja) 1992-03-02 2005-09-09 ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質
US11/580,632 US20070243204A1 (en) 1992-03-02 2006-10-12 Helicobacter pylori proteins useful for vaccines and diagnostics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI920052A IT1262895B (it) 1992-03-02 1992-03-02 Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.

Publications (3)

Publication Number Publication Date
ITFI920052A0 ITFI920052A0 (it) 1992-03-02
ITFI920052A1 true ITFI920052A1 (it) 1993-09-02
IT1262895B IT1262895B (it) 1996-07-22

Family

ID=11349982

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI920052A IT1262895B (it) 1992-03-02 1992-03-02 Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.

Country Status (6)

Country Link
US (1) US6090611A (it)
EP (1) EP0643770B1 (it)
JP (1) JP4271952B2 (it)
AT (2) ATE245698T1 (it)
IT (1) IT1262895B (it)
SG (1) SG48353A1 (it)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
CA2383007A1 (en) * 1992-03-02 1993-09-16 Chiron S.P.A. Helicobacter pylori proteins useful for vaccines and diagnostics
DE69529219T2 (de) * 1994-07-01 2003-11-06 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Helicobacter proteine und impstoffe
AU1463097A (en) * 1996-01-04 1997-08-01 Rican Limited Helicobacter pylori bacterioferritin
US20030185830A1 (en) * 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20060269532A1 (en) * 1997-02-25 2006-11-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7517952B1 (en) * 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20060024301A1 (en) * 1997-02-25 2006-02-02 Corixa Corporation Prostate-specific polypeptides and fusion polypeptides thereof
JP4346821B2 (ja) 1998-04-30 2009-10-21 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｈ．Ｐｙｌｏｒｉによる感染に対する免疫化および処置
US6764687B1 (en) * 1999-06-09 2004-07-20 Akzo Nobel N.V. Live attenuated bacteria for use in a vaccine
US7179609B1 (en) 2000-10-04 2007-02-20 Atrophus Ab Screening method for gastritis
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
EP1423142A1 (en) * 2001-08-31 2004-06-02 Chiron SRL. Helicobacter pylori vaccination with a combination of caga, vaca and nap proteins
SE0200974D0 (sv) 2002-03-27 2002-03-27 Phagen Ab Screening method for gastritis
US20060078919A1 (en) * 2004-09-08 2006-04-13 Harry C. Gurney Janice Gurney Diagnostic test kit and methods of diagnosis and treatment of helicobacter SPP. associated infections
WO2006055623A2 (en) * 2004-11-17 2006-05-26 Drexel University Method and compositions for prevention and treatment of malaria infections
US9568471B2 (en) * 2005-01-25 2017-02-14 The Johns Hopkins University Plasmodium diagnostic assay device
EP1991263B8 (en) 2006-03-01 2015-02-25 Aduro Biotech Engineered listeria and methods of use thereof
SI2640842T1 (sl) 2010-11-17 2018-09-28 Aduro Biotech, Inc. Postopki in sestavki za induciranje imunskega odziva na EGFRvIII
WO2012149045A2 (en) 2011-04-26 2012-11-01 Molecular Express, Inc. Liposomal formulations
KR20150022996A (ko) 2012-06-08 2015-03-04 아두로 바이오테크 암 면역요법을 위한 조성물 및 방법
CN104838004A (zh) 2012-11-06 2015-08-12 艾杜罗生物科技公司 兼性减毒细菌种类及其制备和使用方法
KR20150095668A (ko) 2012-12-13 2015-08-21 아두로 바이오테크, 인코포레이티드 규정된 입체화학을 갖는 환식 퓨린 다이뉴클레오타이드를 포함하는 조성물, 그리고 이의 제조 방법 및 용도
EA201590397A8 (ru) 2012-12-27 2016-08-31 Адуро Биотек, Инк. Способствующие экспрессии антигенных последовательностей у listeria партнеры для гибридизации, представляющие собой сигнальные пептиды, и способы их получения и применения
ES2982836T3 (es) 2013-04-29 2024-10-17 Memorial Sloan Kettering Cancer Center Composiciones y métodos para alterar la señalización de segundos mensajeros
EP2992000B1 (en) 2013-05-03 2020-07-08 The Regents of The University of California Cyclic di-nucleotide induction of type i interferon
SMT201900635T1 (it) 2013-05-18 2020-01-14 Univ California Composizioni e metodi di attivazione della segnalazione dipendente dallo "stimolatore di geni interferone"
US9549944B2 (en) 2013-05-18 2017-01-24 Aduro Biotech, Inc. Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
WO2015017652A1 (en) 2013-07-31 2015-02-05 Memorial Sloan-Kettering Cancer Center Sting crystals and modulators
WO2016061115A1 (en) 2014-10-13 2016-04-21 Providence Health & Services-Oregon D/B/A Providence Portland Medical Center Bacterial vaccines deficient in the 2-c-methyl-d-erythritol-4-phosphate pathway and methods of preparation and use thereof
EP3215139B1 (en) 2014-11-03 2020-08-19 Cerus Corporation Compositions and methods for improved car-t cell therapies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
US4882271A (en) * 1988-03-10 1989-11-21 Baylor College Of Medicine Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection
FR2637612B1 (fr) * 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique
GB8928625D0 (en) * 1989-12-19 1990-02-21 3I Res Expl Ltd H.pylori dna probes
US5292658A (en) * 1989-12-29 1994-03-08 University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center Cloning and expressions of Renilla luciferase
US5354854A (en) * 1991-11-07 1994-10-11 The Curators Of The University Of Missouri Expression system for use in plants to suppress foreign expression and method
US5403924A (en) * 1992-10-13 1995-04-04 Vanderbilt University Taga gene and methods for detecting predisposition to peptic ulceration

Also Published As

Publication number Publication date
ATE382692T1 (de) 2008-01-15
IT1262895B (it) 1996-07-22
EP0643770B1 (en) 2003-07-23
ATE245698T1 (de) 2003-08-15
SG48353A1 (en) 1998-04-17
US6090611A (en) 2000-07-18
JP4271952B2 (ja) 2009-06-03
EP0643770A1 (en) 1995-03-22
JP2003199567A (ja) 2003-07-15
ITFI920052A0 (it) 1992-03-02

Similar Documents

Publication Publication Date Title
ITFI920052A1 (it) Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
CA2131729A1 (en) Helicobacter pylori proteins useful for vaccines and diagnostics
EP1363660A4 (en) HIGHER MOLECULAR VACCINE BASED ON AUTOMPLICATIVE RNA, SUICIDE DNA OR UNDNA DNA VECTOR, WHICH LINKS ANTIGEN WITH A POLYPEPTIDE WHICH PROMOTES THE PRESENTATION OF THE ANTIGEN
ATE312920T1 (de) Dna immunisierung gegen chlamydia infektion
AU2001276619A1 (en) Immunisation against chlamydia pneumoniae
MY119003A (en) Bacterial antigens and vaccine compositions
EA007409B1 (ru) Антигенные полипептиды стрептококков, способы их получения и применения
WO2000066739A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
RU95105518A (ru) Применение мутантов вируса герпеса, вакцина
CY1107950T1 (el) Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
Minnick et al. Cell entry and the pathogenesis of Bartonella infections
CA2217522A1 (en) Isolated frpb nucleic acid molecule and vaccine
Odemuyiwa et al. An outbreak of African swine fever in Nigeria: virus isolation and molecular characterization of the VP72 gene of a first isolate from West Africa
ATE355375T1 (de) Bakterioferritin aus helicobacter pylori
DE69515340D1 (de) Impfstoff gegen mycobakterielle infektionen
NZ526879A (en) Genes and proteins, and their use
ATE417106T1 (de) Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
WO1995020658A3 (en) Diagnosis and treatment of infections due to streptococci and enterococci
WO1992003553A1 (en) Footrot vaccine
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
US20060051363A1 (en) Protein inducing cell death of helicobacter pylori
WO2000011183A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
DE69925927D1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung
NZ512448A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19980327